Table 3.
Univariate and multivariate analysis of EuroSCORE II prognostic factors[2].
| Characteristic | Univariate Analysis | Multivariate Analysisa | ||||
|---|---|---|---|---|---|---|
| β (95% CI) | P value | β (95% CI) | P value | |||
| Age (year)a | 56.3±13.88 | 0.063 (0.058 to 0.068) | <0.001 | 0.058 (0.051 to 0.065) | <0.001 | |
| Gender | Female | 3.5±1.95 | 1 [References] | <0.001 | 1 [Reference] | |
| Male | 2.6±2.16 | -0.88 (-1.05 to -0.72) | -0.82 (-0.98 to -0.66) | <0.001 | ||
| Creatinine clearance | <50 | 4.4±2.16 | 1 [References] | <0.001 | 1 [Reference] | |
| 50-85 | 2.9±1.99 | -1.49 (-1.70 to -1.28) | -0.92 (-1.13 to -0.71) | <0.001 | ||
| >85 | 1.8±1.53 | -2.57 (-2.8 to -2.34) | -1.06 (-1.32 to -0.79) | <0.001 | ||
| Dialysis | 3.0±2.31 | -1.33 (-2.12 to -0.55) | -0.78 (-1.73 to -0.02) | 0.045 | ||
| Chronic lung disease | No | 2.9±2.11 | 1 [References] | 0.061 | 1 [Reference] | |
| Yes | 3.5±2.43 | 0.54 (-0.03 to 1.10) | 0.15 (-0.31 to 0.61) | 0.529 | ||
| Diabetes on insulin | No | 3.0±2.12 | 1 [References] | 0.859 | 1 [Reference] | |
| Yes | 2.9±2.14 | -0.02 (-0.22 to 0.18) | -0.19 (-0.37 to -0.01) | 0.043 | ||
| NYHA | Class I | 2.4±1.97 | 1 [References] | <0.001 | 1 [Reference] | |
| Class II | 2.9±2.18 | 0.47 (0.18 to 0.77) | 0.2 (-0.002 to 0.40) | 0.052 | ||
| Class III | 3.3±2.09 | 0.86 (0.56 to 1.17) | 0.14 (-0.07 to 0.35) | 0.199 | ||
| Class IV | 3.8±1.98 | 1.44 (0.81 to 2.07) | 0.52 (0.08 to 0.95) | 0.019 | ||
| Left ventricular function | ≤50 | 3.5±2.19 | 1 [References] | <0.001 | 1 [Reference] | |
| 51-70 | 2.3±1.84 | -1.22 (-1.40 to -1.03) | -0.87 (-1.03 to -0.70) | <0.001 | ||
| >70 | 2.0 ± 1.76 | -1.52 (-2.43 to -0.61) | -1.37 (-2.06 to -0.69) | <.001 | ||
| Recent myocardial infarction | No | 2.8±2.07 | 1 [References] | <0.001 | 1 [Reference] | |
| Yes | 4.7±2.19 | 1.81 (1.48 to 2.14) | 1.86 (1.56 to 2.15) | <0.001 | ||
| Pulmonary hypertension | No | 2.8±2.03 | 1 [References] | <0.001 | 1 [Reference] | |
| Yes | 5.2±1.99 | 2.41 (2.11 to 2.71) | 2.04 (1.77 to 2.31) | <0.001 | ||
| Weight of the intervention | Isolated CABG | 2.7±2.06 | 1 [References] | <0.001 | 1 [Reference] | |
| Single non-CABG | 4.1±2.02 | 1.38 (1.14 to 1.62) | 1.48 (1.25 to 1.72) | <0.001 | ||
| 2 Procedures | 4.2±1.93 | 1.55 (1.21 to 1.90) | 1.89 (1.56 to 2.22) | <0.001 | ||
| 3 Procedures | 4.1±1.6 | 1.45 (0.74 to 2.15) | 1.58 (0.91 to 2.25) | <0.001 | ||
a
Using linear regression, all variables were found to be associated with EuroSCORE II, except for chronic lung disease, diabetes on insulin, and NYHA.
NYHA=New York Heart Association; CABG=coronary artery bypass graft